Bellecapital’s CVS Health CVS Stock Holding History

Bellecapital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-34,186	Closed	-$2.24M	–	120
2018 Q4	$2.24M	Sell	34,186 -1,411	-4%	-$105K	1.6%	21
2018 Q3	$2.8M	Sell	35,597 -3,317	-9%	-$237K	1.84%	20
2018 Q2	$2.5M	Buy	38,914 +12,503	+47%	+$824K	1.81%	20
2018 Q1	$1.64M	Sell	26,411 -16,049	-38%	-$1.15M	1.54%	21
2017 Q4	$3.08M	Buy	42,460 +13,983	+49%	+$1.02M	2.49%	17
2017 Q3	$2.32M	Sell	28,477 -23,796	-46%	-$1.88M	2.73%	15
2017 Q2	$4.21M	Sell	52,273 -2,108	-4%	-$166K	3.69%	11
2017 Q1	$4.27M	Buy	54,381 +1,391	+3%	+$111K	3.95%	8
2016 Q4	$4.18M	Buy	+52,990	New	+$4.29M	3.72%	10

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return